Satsuma Pharmaceuticals, Inc.
5 clinical trials · Sponsor
◉ Watch Satsuma Pharmaceuticals, Inc.
| Record | Firm | Date |
|---|---|---|
| A Randomized, Double-Blind, Parallel Group, Placebo-Controlled Study to Assess STS101 in the Acute Treatment of Migraine (NCT04940390) | Satsuma Pharmaceuticals, Inc. | 2021-06-30 |
| A Study of the PK and Safety of Single Doses of STS101, DHE Injection and Nasal Spray in Healthy Subjects (NCT05337254) | Satsuma Pharmaceuticals, Inc. | 2021-03-05 |
| A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate STS101 in the Acute Treatment of Migraine (NCT03901482) | Satsuma Pharmaceuticals, Inc. | 2019-06-24 |
| A Phase I Study to Study the PK and Safety of Single Doses of STS101, DHE Injection and Nasal Spray in Healthy Subjects (NCT03874832) | Satsuma Pharmaceuticals, Inc. | 2018-09-11 |
Track Satsuma Pharmaceuticals, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.